Venus Medtech
IPOPublic · Hangzhou, China · Founded 2009
- Headquarters
- Hangzhou
- Employees
- 501–1000
- Founded
- 2009
- Business Model
- B2B
- Website
- venusmedtech.com
- Type
- Public
About
Venus Medtech (Hangzhou) Inc. is the leading provider of transcatheter structural heart valve therapies in China, with a product pipeline spanning all four heart valves plus renal denervation therapy for hypertension. Founded in 2009 and headquartered in Hangzhou's National High-Tech Industrial Development Zone (Binjiang), the company listed on the Hong Kong Stock Exchange in December 2019 (2500.HK) and holds an intellectual property portfolio of more than 800 patents and patent applications as of December 2023.
Summary
Venus Medtech is a Healthcare company based in Hangzhou, China, founded in 2009.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
operates in the healthcare industry focusing on biotechnology business
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...